Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias.
M. Anderson.
Pharmacol. Ther. 106 (1): 39--55 (April 2005)

The multifunctional Ca$^2+$/calmodulin (CaM)-dependent protein kinase II (CaMKII) has emerged as a proarrhythmic and procardiomyopathic signal in a wide range of structural heart diseases. This review discusses CaMKII structure and function and recent evidence implicating CaMKII inhibition as a potential strategy for treating myocardial dysfunction and arrhythmias in the setting of structural heart disease.

URL

http://dx.doi.org/10.1016/j.pharmthera.2004.11.002

DOI

10.1016/j.pharmthera.2004.11.002

search on

This publication has not been reviewed yet.

rating distribution

average user rating0.0 out of 5.0 based on 0 reviews

Please log in to take part in the discussion (add own reviews or comments).

@article{Ande_2005_39,
  abstract = {The multifunctional {C}a$^{2+}$/calmodulin (CaM)-dependent protein
	kinase II (CaMKII) has emerged as a proarrhythmic and procardiomyopathic
	signal in a wide range of structural heart diseases. This review
	discusses CaMKII structure and function and recent evidence implicating
	CaMKII inhibition as a potential strategy for treating myocardial
	dysfunction and arrhythmias in the setting of structural heart disease.},
  added-at = {2009-06-03T11:20:58.000+0200},
  author = {Anderson, Mark E},
  biburl = {https://www.bibsonomy.org/bibtex/27170fdd28ee17c0dc0529075a31e7bf4/hake},
  description = {The whole bibliography file I use.},
  doi = {10.1016/j.pharmthera.2004.11.002},
  file = {Ande_2005_39.pdf:Ande_2005_39.pdf:PDF},
  interhash = {6ea79f10706773291ee5d6bd7ef4a3c2},
  intrahash = {7170fdd28ee17c0dc0529075a31e7bf4},
  journal = {Pharmacol. Ther.},
  key = 287,
  keywords = {80 AMP-Dependent Action Adenoma, Adjuvant, Adolescent, Adrenergic Adul, Adult, Aged, Aldehydes, Alveolar Analysis Animals, Antineoplastic Arrhythmia, Atrial Atrioventricular Biological, C57BL, Calcium Calcium, Capillaries, Cardiac Cardiomegaly, Cardiomyopathies, Cell Channels, Chemotherapy Chemotherapy, Choristoma, Cohort Combined Computer-Assisted, Congestive, Cyclic Cyclophosphamide, Dacarbazine, Dependent Diagnosis, Differential, Disease Disease, Diseases, Doxorubicin, Enzymologic, Expression Extramural, Failure, Female, Fibrillation, Flecainide, Gastrointestinal Gene Genetic Genetic, Heart Heart, Hematoma, Hemorrhage, Homeostasis, Humans, Ifosfamide, Image Inbred Isoprostanes, Isoproterenol, Kinase, Kinases, Knockout, L-Type, Line, Lipid Long Low, Male, Mediastinal Mesna, Node, Output, Part, Peroxidation, Potentials, Predisposition Processing, Protein Protocols, QT Regulation, Screening, Soft Studies, Susceptibility, Syndrome, Variance, and beta-Antagonists, of over, to {C}a$^{2+}$-Calmodulin},
  month = Apr,
  number = 1,
  pages = {39--55},
  pdf = {Ande_2005_39.pdf},
  pii = {S0163-7258(04)00197-4},
  pmid = {15781121},
  timestamp = {2009-06-03T11:21:00.000+0200},
  title = {Calmodulin kinase signaling in heart: an intriguing candidate target
	for therapy of myocardial dysfunction and arrhythmias.},
  url = {http://dx.doi.org/10.1016/j.pharmthera.2004.11.002},
  volume = 106,
  year = 2005
}

%0 Journal Article
%1 Ande_2005_39
%A Anderson, Mark E
%D 2005
%J Pharmacol. Ther.
%K 80 AMP-Dependent Action Adenoma, Adjuvant, Adolescent, Adrenergic Adul, Adult, Aged, Aldehydes, Alveolar Analysis Animals, Antineoplastic Arrhythmia, Atrial Atrioventricular Biological, C57BL, Calcium Calcium, Capillaries, Cardiac Cardiomegaly, Cardiomyopathies, Cell Channels, Chemotherapy Chemotherapy, Choristoma, Cohort Combined Computer-Assisted, Congestive, Cyclic Cyclophosphamide, Dacarbazine, Dependent Diagnosis, Differential, Disease Disease, Diseases, Doxorubicin, Enzymologic, Expression Extramural, Failure, Female, Fibrillation, Flecainide, Gastrointestinal Gene Genetic Genetic, Heart Heart, Hematoma, Hemorrhage, Homeostasis, Humans, Ifosfamide, Image Inbred Isoprostanes, Isoproterenol, Kinase, Kinases, Knockout, L-Type, Line, Lipid Long Low, Male, Mediastinal Mesna, Node, Output, Part, Peroxidation, Potentials, Predisposition Processing, Protein Protocols, QT Regulation, Screening, Soft Studies, Susceptibility, Syndrome, Variance, and beta-Antagonists, of over, to {C}a$^{2+}$-Calmodulin
%N 1
%P 39--55
%R 10.1016/j.pharmthera.2004.11.002
%T Calmodulin kinase signaling in heart: an intriguing candidate target
	for therapy of myocardial dysfunction and arrhythmias.
%U http://dx.doi.org/10.1016/j.pharmthera.2004.11.002
%V 106
%X The multifunctional Ca$^2+$/calmodulin (CaM)-dependent protein
	kinase II (CaMKII) has emerged as a proarrhythmic and procardiomyopathic
	signal in a wide range of structural heart diseases. This review
	discusses CaMKII structure and function and recent evidence implicating
	CaMKII inhibition as a potential strategy for treating myocardial
	dysfunction and arrhythmias in the setting of structural heart disease.

BibSonomy

Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias.
M. Anderson.
Pharmacol. Ther. 106 (1): 39--55 (April 2005)

Tags

Users

Comments and Reviews

Cite this publication

BibSonomy

Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias.M. Anderson. Pharmacol. Ther. 106 (1): 39--55 (April 2005)

Tags

Users

Comments and Reviews

Cite this publication

Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias.
M. Anderson.
Pharmacol. Ther. 106 (1): 39--55 (April 2005)